Indocoar Pharma Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
- Paid Up Capital ₹ 2.70 Cr
- Company Age 39 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 17.03 Cr
- Satisfied Charges ₹ 5.89 Cr
- Revenue Growth 102.56%
- Profit Growth 117.27%
- Ebitda 183.01%
- Net Worth 17.05%
- Total Assets 4.22%
About Indocoar Pharma
Indocoar Pharma Private Limited (IPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 04 October 1985 and has a history of 39 years and four months. Its registered office is in Bangaluru, Karnataka, India.
The Corporate was formerly known as M Apotheke Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 2.70 Cr.
The company currently has active open charges totaling ₹17.03 Cr. The company has closed loans amounting to ₹5.89 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shetty Shweta and Chandrakanth Mahalingashetty serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24239KA1985PTC007188
-
Company No.
007188
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Oct 1985
-
Date of AGM
25 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Indocoar Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandrakanth Mahalingashetty
|
Managing Director | 04-Oct-1985 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Shetty Shweta
|
Director | 24-Jan-2018 | Current |
Financial Performance of Indocoar Pharma.
Indocoar Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 102.56% increase. The company also saw a substantial improvement in profitability, with a 117.27% increase in profit. The company's net worth Soared by an impressive increase of 17.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indocoar Pharma?
In 2023, Indocoar Pharma had a public holding of 54.30%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
M C O Hospital Aids Private LimitedChandrakanth Mahalingashetty is a mutual person
Charges (Loans)
₹17.03 Cr
₹5.89 Cr
Charges Breakdown by Lending Institutions
- Others : 17.03 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Dec 2023 | Others | ₹7.25 M | Open |
| 21 Mar 2022 | Others | ₹1.65 M | Open |
| 02 Dec 2019 | Others | ₹15.84 Cr | Open |
| 29 May 2018 | Others | ₹3.00 M | Open |
| 28 Sep 2010 | Union Bank Of India | ₹3.50 Cr | Satisfied |
How Many Employees Work at Indocoar Pharma?
Indocoar Pharma has a workforce of 48 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indocoar Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indocoar Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
